The Coronary Reperfusion Effect and Safety of Prehospital P2Y12 Inhibitor in Primary-PCI STEMI Patients: A systematic review and Meta-analysis
CONCLUSION: Prehospital P2Y12 inhibitor compared to in-hospital P2Y12 inhibitor is associated with a significantly higher rate of pre-PCI and post-PCI TIMI flow grade 2-3, a reduced risk of recurrent MI, and no increase in major bleeding in STEMI patients undergoing primary PCI.PMID:38019694 | DOI:10.1080/10903127.2023.2284819
Source: Prehospital Emergency Care - Category: Endocrinology Authors: Yung-Hua Chou Cheng-Chieh Huang Chia-Kai Chang Jing-Lan Huang Bo-Han Jang Tsung-Han Lee Kun-Te Lin Wen-Liang Chen Chu-Chung Chou Yan-Ren Lin Source Type: research
More News: Angioplasty | Bleeding | Chia | Conferences | Coronary Angioplasty | Databases & Libraries | Emergency Medicine | Endocrinology | Heart Attack | Percutaneous Coronary Intervention | Study